首页> 外文期刊>Oman Journal of Ophthalmology >Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
【24h】

Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration

机译:玻璃体腔注射贝伐单抗治疗老年性黄斑变性引起的脉络膜新生血管后形成层状性黄斑裂孔

获取原文
           

摘要

This report describes a lamellar macular hole formation subsequent to intravitreal bevacizumab injection for the treatment of choroidal neovascularization (CNV) by age-related macular degeneration. A 67-year-old woman with bilateral CNV underwent 3 monthly intravitreal bevacizumab injections in her both eyes. One month after the third bilateral injection, vision loss happened. Optical coherence tomography performed for further evaluation that showed reduction of intra- and sub-retinal fluid associated with lamellar macular hole development in both eyes. Although macular hole formation, especially bilateral form, is a rare complication of intravitreal injections, surgeons should consider macular hole development in cases with vision deterioration following intravitreal bevacizumab injection.
机译:该报告描述了玻璃体内贝伐单抗注射后用于治疗年龄相关性黄斑变性的脉络膜新生血管(CNV)的层状黄斑裂孔。一名67岁的女性患有双侧CNV,她的双眼每月接受3次玻璃体内贝伐单抗注射。第三次双边注射后一个月,发生视力丧失。进行了光学相干断层扫描以进一步评估,结果显示与两只眼的层状黄斑裂孔相关的视网膜内和视网膜下液减少。尽管黄斑裂孔形成,特别是双侧形成是玻璃体内注射的罕见并发症,但在玻璃体内贝伐单抗注射后视力下降的情况下,外科医生应考虑黄斑裂孔的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号